156 related articles for article (PubMed ID: 30324876)
1. Estrogen Receptor Alpha and its Ubiquitination in Breast Cancer Cells.
Tecalco-Cruz AC; Ramírez-Jarquín JO; Cruz-Ramos E
Curr Drug Targets; 2019; 20(6):690-704. PubMed ID: 30324876
[TBL] [Abstract][Full Text] [Related]
2. Identification of an estrogen receptor α non covalent ubiquitin-binding surface: role in 17β-estradiol-induced transcriptional activity.
Pesiri V; La Rosa P; Stano P; Acconcia F
J Cell Sci; 2013 Jun; 126(Pt 12):2577-82. PubMed ID: 23591816
[TBL] [Abstract][Full Text] [Related]
3. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
[TBL] [Abstract][Full Text] [Related]
4. The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation.
Zhu J; Zhao C; Kharman-Biz A; Zhuang T; Jonsson P; Liang N; Williams C; Lin CY; Qiao Y; Zendehdel K; Strömblad S; Treuter E; Dahlman-Wright K
Oncogene; 2014 Aug; 33(34):4340-51. PubMed ID: 24441041
[TBL] [Abstract][Full Text] [Related]
5. TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α.
Tang J; Luo Y; Tian Z; Liao X; Cui Q; Yang Q; Wu G
Neoplasia; 2020 Sep; 22(9):343-351. PubMed ID: 32599554
[TBL] [Abstract][Full Text] [Related]
6. Selective binding of estrogen receptor α to ubiquitin chains.
Pesiri V; Di Muzio E; Polticelli F; Acconcia F
IUBMB Life; 2016 Jul; 68(7):569-77. PubMed ID: 27193211
[TBL] [Abstract][Full Text] [Related]
7. Deubiquitination and stabilization of estrogen receptor α by ubiquitin-specific protease 7 promotes breast tumorigenesis.
Xia X; Liao Y; Huang C; Liu Y; He J; Shao Z; Jiang L; Dou QP; Liu J; Huang H
Cancer Lett; 2019 Nov; 465():118-128. PubMed ID: 31518603
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin ligase RNF2 stabilizes ERα and modulates breast cancer progression.
Yuan L; Li X; Yang H; Li H
Hum Cell; 2023 Jan; 36(1):353-365. PubMed ID: 36271315
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin ligase RNF181 stabilizes ERα and modulates breast cancer progression.
Zhu J; Li X; Su P; Xue M; Zang Y; Ding Y
Oncogene; 2020 Oct; 39(44):6776-6788. PubMed ID: 32973333
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor alpha phosphorylation and its functional impact in human breast cancer.
Anbalagan M; Rowan BG
Mol Cell Endocrinol; 2015 Dec; 418 Pt 3():264-72. PubMed ID: 25597633
[TBL] [Abstract][Full Text] [Related]
11. The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression.
Xia X; Huang C; Liao Y; Liu Y; He J; Shao Z; Hu T; Yu C; Jiang L; Liu J; Huang H
Cell Death Dis; 2021 Mar; 12(4):329. PubMed ID: 33771975
[TBL] [Abstract][Full Text] [Related]
12. Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression.
Zhu J; Zhuang T; Yang H; Li X; Liu H; Wang H
BMC Cancer; 2016 Jul; 16():538. PubMed ID: 27460922
[TBL] [Abstract][Full Text] [Related]
13. Nucleo-cytoplasmic transport of estrogen receptor alpha in breast cancer cells.
Tecalco-Cruz AC; Pérez-Alvarado IA; Ramírez-Jarquín JO; Rocha-Zavaleta L
Cell Signal; 2017 Jun; 34():121-132. PubMed ID: 28341599
[TBL] [Abstract][Full Text] [Related]
14. FOXK2 transcription factor suppresses ERα-positive breast cancer cell growth through down-regulating the stability of ERα via mechanism involving BRCA1/BARD1.
Liu Y; Ao X; Jia Z; Bai XY; Xu Z; Hu G; Jiang X; Chen M; Wu H
Sci Rep; 2015 Mar; 5():8796. PubMed ID: 25740706
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic ubiquitin E3 ligase activity of histone acetyltransferase Hbo1 for estrogen receptor α.
Iizuka M; Susa T; Tamamori-Adachi M; Okinaga H; Okazaki T
Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(7):498-510. PubMed ID: 28769019
[TBL] [Abstract][Full Text] [Related]
16. Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer.
Tecalco-Cruz AC; Ramírez-Jarquín JO
World J Clin Oncol; 2018 Aug; 9(4):60-70. PubMed ID: 30148069
[TBL] [Abstract][Full Text] [Related]
17. BCAS2 Enhances Carcinogenic Effects of Estrogen Receptor Alpha in Breast Cancer Cells.
Salmerón-Hernández Á; Noriega-Reyes MY; Jordan A; Baranda-Avila N; Langley E
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813351
[TBL] [Abstract][Full Text] [Related]
18. COPS5 amplification and overexpression confers tamoxifen-resistance in ERα-positive breast cancer by degradation of NCoR.
Lu R; Hu X; Zhou J; Sun J; Zhu AZ; Xu X; Zheng H; Gao X; Wang X; Jin H; Zhu P; Guo L
Nat Commun; 2016 Jul; 7():12044. PubMed ID: 27375289
[TBL] [Abstract][Full Text] [Related]
19. Different epigenetic mechanisms of ERα implicated in the fate of fulvestrant-resistant breast cancer.
Tsuboi K; Kaneko Y; Nagatomo T; Fujii R; Hanamura T; Gohno T; Yamaguchi Y; Niwa T; Hayashi SI
J Steroid Biochem Mol Biol; 2017 Mar; 167():115-125. PubMed ID: 27888136
[TBL] [Abstract][Full Text] [Related]
20. MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α.
Tang J; Luo Y; Long G; Zhou L
Cell Death Dis; 2021 Oct; 12(10):937. PubMed ID: 34645792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
